West Pharmaceutical Services (WST) FCF Payout Ratio (2009 - 2026)

West Pharmaceutical Services has disclosed FCF Payout Ratio across 18 years of filings, most recently posting 0.25 for Q1 2026.

• FCF Payout Ratio for Q1 2026 came in at 0.25, down 5.34% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.13 (up 28.03% YoY), and the FY2025 annual result was 0.13, up 32.59% from the prior year.
• FCF Payout Ratio came in at 0.25 for Q1 2026 at West Pharmaceutical Services, up from 0.09 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 0.26 in Q1 2025 to a low of 0.29 in Q3 2024.
• The 5-year median for FCF Payout Ratio is 0.12 (2022), against an average of 0.12.
• Across the five-year window, FCF Payout Ratio soared 211.75% in 2023 and slumped 375.98% in 2024, its largest moves.
• West Pharmaceutical Services' FCF Payout Ratio stood at 0.04 in 2022, then jumped by 211.75% to 0.11 in 2023, then plunged by 67.06% to 0.04 in 2024, then jumped by 141.47% to 0.09 in 2025, then jumped by 174.29% to 0.25 in 2026.
• The last three FCF Payout Ratio figures came in at 0.25 (Q1 2026), 0.09 (Q4 2025), and 0.11 (Q3 2025), per Business Quant data.